Hisani Madison and I met as trainees in the NCI Cancer Prevention Fellowship Program. She recently transitioned from working at the U.S. Food and Drug Administration (FDA) to AstraZeneca. Of course, I was really intrigued about her transition from the FDA to working in pharma. I also thought that maybe our blog readers might be interested in this too! So I asked her to answer some questions for this blog post. Thank you to Hisani for being so generous in sharing her experiences with us!
